How big is the digital pathology market?

The global digital pathology market size was estimated at USD 1.53 billion in 2025 and is expected to reach USD 1.64 billion in 2026.

What is the digital pathology market growth?

The global digital pathology market is expected to grow at a compound annual growth rate of 8.6% from 2026 to 2033 to reach USD 2.97 billion by 2033.

Which segment accounted for the largest digital pathology market share?

North America dominated the global digital pathology market with the largest revenue share of 39.92% in 2025. This is attributable to the deployment of R&D investments, supportive government initiatives, technologically advanced systems, rising adoption of digital imaging, and the presence of major players.

Who are the key players in the digital pathology market?

Some key players operating in the digital pathology market include Leica Biosystems Nussloch GmbH (Danaher); Hamamatsu Photonics, Inc.; Koninklijke Philips N.V.; Olympus Corp.; F. Hoffmann-La Roche Ltd.; Mikroscan Technologies, Inc.; Inspirata, Inc.; Epredia (3DHISTECH Ltd.); Visiopharm A/S; Huron Technologies International Inc.; ContextVision AB; HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO); West Medica Produktions- und Handels- GmbH (West Medica); IBEX (IBEX MEDICAL ANALYTICS); SigTuple Technologies Private Limited; Morphle Labs, Inc.; Bionovation Biotech, Inc.; Scopio labs; Path Hub; Sectra AB; Agfa-Gevaert Group; OptraScan; Agilent Technologies, Inc.; KFBIO; CellaVision. Aiosyn; Proscia Inc.; EVIDENT; Aignostics, Inc.; Aiforia; Dedalus S.p.A; Qritive; Mindpeak GmbH; CGI Inc.; aetherAI; Gestalt

What are the factors driving the digital pathology market?

Key factors that are driving the digital pathology market growth include rising prevalence of cancer, increasing focus on improving the efficiency of workflow, and growing demand for faster diagnostic tools. Moreover, rising investments in healthcare aided by major key players operating in the market focusing on new launches, increasing adoption of telepathology, and an increasing focus on drug discovery and precision medicine is propelling the market growth.